Ziyaad Waja to Female
This is a "connection" page, showing publications Ziyaad Waja has written about Female.
Connection Strength
0,211
-
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. Emerg Infect Dis. 2025 Mar; 31(3):467-476.
Score: 0,023
-
Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility. Clin Immunol. 2021 09; 230:108824.
Score: 0,018
-
Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. Tuberculosis (Edinb). 2021 07; 129:102103.
Score: 0,018
-
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
Score: 0,018
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
Score: 0,018
-
Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
Score: 0,017
-
Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort. Clin Infect Dis. 2020 09 12; 71(6):1419-1426.
Score: 0,017
-
Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting. J Mol Diagn. 2020 10; 22(10):1225-1237.
Score: 0,017
-
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV. Int J Tuberc Lung Dis. 2020 07 01; 24(7):681-685.
Score: 0,017
-
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV. Antimicrob Agents Chemother. 2020 02 21; 64(3).
Score: 0,017
-
Chronic HIV-1 Infection Alters the Cellular Distribution of Fc?RIIIa and the Functional Consequence of the Fc?RIIIa-F158V Variant. Front Immunol. 2019; 10:735.
Score: 0,016
-
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
Score: 0,014